Abstract:Safe and effective photothermal therapy depends on efficient delivery of heat for killing cells and molecular specificity for targeting cells. To address these requirements, we have designed an aptamer-based nanostructure which combines the high absorption efficiency of Au-Ag nanorods with the target specificity of molecular aptamers, a combination resulting in the development of an efficient and selective therapeutic agent for targeted cancer cell photothermal destruction. Most nanomaterials, such as gold nanoshells or nanorods (NRs), require a relatively high power of laser irradiation (1 x 10(5)-1 x 10(10).W/m(2)). In contrast, the high absorption characteristic of our Au-Ag NRs requires only 8.5 x 10(4) W/m(2) laser exposure to induce 93 (+/- 11)% cell death of NR-aptamer-labeled cells. Aptamers, the second component of the nanostructure, are generated from a cell-SELEX (systematic evolution of ligands by exponential enrichment) process and can be easily selected for specific recognition of individual tumor cell types without prior knowledge of the biomarkers for the cell. When tested with both cell suspensions and artificial solid tumor samples, these aptamer conjugates were shown to have excellent hyperthermia efficiency and selectivity. Under a specific laser intensity and duration of laser exposure, about 50 (+/- 1)% of target (CEM) cells were severely damaged, while more than 87 (+/- 1)% of control (NB-4) cells remained intact in a suspension cell mixture. These results indicate that the Au-Ag nanorod combination offers selective and efficient photothermal killing of targeted tumor cells, thus satisfying the two key challenges noted above. Consequently, for future in vivo application, it is fully anticipated that the tumor tissue will be selectively destroyed at laser energies which will not harm the surrounding normal tissue.

Assembly of Aptamer Switch Probes and Photosensitizer on Gold Nanorods for Targeted Photothermal and Photodynamic Cancer Therapy.

Molecular Assembly Of Dna Aptamer And Photosensitizer For Targeting Cancer Therapy

Photosensitizer-Gold Nanorod Composite for Targeted Multimodal Therapy

Gold Nanorod-Photosensitizer Conjugate with Extracellular Ph-Driven Tumor Targeting Ability for Photothermal/photodynamic Therapy

Photosensitizer Anchored Gold Nanorods for Targeted Combinational Photothermal and Photodynamic Therapy.

Combined Photodynamic and Photothermal Therapy Using Cross-Linked Polyphosphazene Nanospheres Decorated with Gold Nanoparticles

Fluorescence Guided Photothermal/photodynamic Ablation of Tumours Using Ph-Responsive Chlorin E6-Conjugated Gold Nanorods

Tlyp-1-conjugated Au-nanorod@SiO(2) Core-Shell Nanoparticles for Tumor-Targeted Drug Delivery and Photothermal Therapy.

New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic–photothermal therapy

Tumor Antigen Mediated Conformational Changes of Nanoplatform for Activated Photodynamic Therapy

A photoresponsive and rod-shape nanocarrier: Single wavelength of light triggered photothermal and photodynamic therapy based on AuNRs-capped & Ce6-doped mesoporous silica nanorods

Aluminum Phthalocyanine and Gold Nanorod Conjugates: the Combination of Photodynamic Therapy and Photothermal Therapy to Kill Cancer Cells

Targeted Photodynamic Therapy Activities of Surface-Enhanced Raman Scattering-Active Theranostic System Based on Folate/Hyaluronic Acid-Functionalized Gold Nanochains.

Selective Photothermal Therapy For Mixed Cancer Cells Using Aptamer-Conjugated Nanorods

Gold Nanorod-Seeded Synthesis of Au@Ag/Au Nanospheres with Broad and Intense Near-Infrared Absorption for Photothermal Cancer Therapy

Synergistic Effect to Kill Cancer Cells by Gold Nanorod-Aluminum Phthalocyanine Conjugates

Synthesis of Porphyrin-Conjugated Silica-Coated Au Nanorods for Synergistic Photothermal Therapy and Photodynamic Therapy of Tumor

Activatable Albumin-Photosensitizer Nanoassemblies for Triple-Modal Imaging and Thermal-Modulated Photodynamic Therapy of Cancer.

Au@Pt Nanostructures: a Novel Photothermal Conversion Agent for Cancer Therapy.

High Aspect Ratio Plasmonic Au/Ag Nanorods-Mediated NIR-II Photothermally Enhanced Nanozyme Catalytic Cancer Therapy.

Plasmon-Triggered Upconversion Emissions and Hot Carrier Injection for Combinatorial Photothermal and Photodynamic Cancer Therapy